The NKG2D-mediated immune response plays a crucial role in tumor surveillance, and the NKG2D pathway can regulate tumor initiation and progression, which is essential for ensuring the efficacy of CAR-NK in solid tumors [53]. Here, KLRK1 is linked to neoplasm.